ASCO 2026.3.4 Living Guideline: Lorlatinib Takes Priority in First-Line ALK-Positive NSCLC After Landmark Seven-Year CROWN Results
2026 Prix Galien Awards Recognize Major Advances in Cancer Treatment, Screening and Immunotherapy
FASCO 2027: Recognizing Dedication to Oncology
Carla Ferrell and Sista Strut 2026: Breast Cancer Awareness Mission
Adding SPICE to SBRT: Intentional Hotspots Associated with Improved Local Control in Early-Stage NSCLC
Top Gastroesophageal Cancer Updates From ESMO 2026
Can the Tumor’s Own B Cells Reveal the Next Immunotherapy Target?
Re-Irradiation in Pediatric CNS Tumors: Balancing a Second Chance of Cure Against Long-Term Toxicity
The ASCO Breakthrough 2027 meeting, co-hosted by the American Society of Clinical Oncology (ASCO) and the Singapore Society of Oncology, will take place on June 24–26, 2027, at the Raffles City Convention Centre in Singapore, with virtual participation also available. The international meeting will bring together oncologists, cancer researchers, clinicians, and healthcare professionals from across […]
